RECRUITING

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation

Description

The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation of the ovaries and reduce both cost and injection burden for patients. Participants will be randomized to receive the long Clomid protocol vs. the typical protocol involving Clomid only for 5 days followed by growth hormone-releasing hormone (GnRH) antagonist. The primary outcome the investigators will evaluate will be the number of mature eggs retrieved.

Study Overview

Study Details

Study overview

The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation of the ovaries and reduce both cost and injection burden for patients. Participants will be randomized to receive the long Clomid protocol vs. the typical protocol involving Clomid only for 5 days followed by growth hormone-releasing hormone (GnRH) antagonist. The primary outcome the investigators will evaluate will be the number of mature eggs retrieved.

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation in Patients With Diminished Ovarian Reserve Undergoing In-vitro Fertilization: a Randomized Controlled Trial

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation

Condition
Infertility, Female
Intervention / Treatment

-

Contacts and Locations

Pasadena

HRC Fertility, Pasadena, California, United States, 91101

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Undergoing IVF
  • * Must meet POSEIDON criteria based on clinic evaluation
  • * Female partner: Antral follicle count of 2 or more and age \<45 at time of stimulation start
  • * Male partner/sperm source: Cannot be azoospermic
  • * Planning freeze-all cycle (regardless of blastocyst or cleavage stage culture) or fresh transfer if randomized to short Clomid group
  • * Planning 36-hour trigger window
  • * Normal ovarian reserve or good response
  • * Allergy or adverse reaction to Clomid
  • * Minimal stimulation protocols
  • * History of prior premature ovulation

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Southern California,

Richard Paulson, PRINCIPAL_INVESTIGATOR, paulsonivf@havingbabies.com

Study Record Dates

2027-12